ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ranolazine Mechanism of Action, Manufacturing Process, and API manufacturers in China
May 17, 2021Ranolazine is a piperazine derivative belonging to the anti-anginal class of drugs. It is mainly used for the management of stable angina pectoris. Chronic angina leads to ongoing chest pain or pressure, which is felt when the heart does not receive enoug -
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine
July 09, 2019Glenmark Pharmaceuticals has been granted final approval by the United States Food and Drug Administration (US FDA) for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg ...
Pharma Sources Insight January 2025
